Rubicon Research Ltd.

NSE: RUBICON | BSE: 544578 | ISIN: INE506V01022 | Industry: Pharmaceuticals
| Expensive Performer
1202.5000 -95.70 (-7.37%)
NSE Jun 05, 2026 15:31 PM
Volume: 637.7K
High vol.+gain this week

logo
Rubicon Research Ltd.
13 Nov 2025
1202.50
-7.37%

Outperformance across metrics; stellar start to the post-IPO phase

buy
by Motilal Oswal
Target: 780
Motilal Oswal
Rubicon Research (Rubicon) delivered better-than-expected performance, with a 7%/18%/21% beat on revenue/EBITDA/PAT for the quarter.
 
Motilal Oswal increased Buy price target of Rubicon Research Ltd. to 1160.0 on 30 May, 2026.
More from Rubicon Research Ltd.
Recommended
Five Interesting Stocks Today - June 5, 2026
The Baseline | 05 Jun 2026
Market trades lower, Bajaj Electricals to expand into the cables business
Trendlyne Marketwatch | 05 Jun 2026
Is a dual threat coming for the Indian economy?
The Baseline | 04 Jun 2026